← Back to Search

Telerehabilitation (TH) for Chronic Obstructive Pulmonary Disease (CHIEF-PR Trial)

N/A

Waitlist Available

Led By Joseph Finkelstein, MD

Research Sponsored by Icahn School of Medicine at Mount Sinai

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a new system called CHIEF-PR that uses technology to help COPD patients stick to their lung exercises. It targets patients who had a flare-up and combines computer counseling with remote monitoring to keep them on track.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Percentage of patients who completed the program

Secondary study objectives

6 minute walking distance

COPD self-efficacy Scale (CSES)

Chronic Respiratory Disease Questionnaire (CRDQ)

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Telerehabilitation (TH)Experimental Treatment1 Intervention

Group II: Best available care (BAC)Active Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor

903 Previous Clinical Trials

541,798 Total Patients Enrolled

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,931 Previous Clinical Trials

47,766,588 Total Patients Enrolled

Joseph Finkelstein, MD4.47 ReviewsPrincipal Investigator - Icahn School of Medicine at Mount Sinai

Icahn School of Medicine at Mount Sinai

1Patient Review

I was 35 when I had to terminate my pregnancy at 22 weeks. My son had Trisomy 18, which was unfortunately not picked up on an ultrasound or an AFP. I have never understood why. I was always told that Dr. Finkelstein was very straightforward with my other two pregnancies, but I thought he would have had more compassion for this situation. I still think about it 51.